Outcomes of patients with secondary central nervous system lymphoma following CAR T-cell therapy: a multicenter cohort study.

J Hematol Oncol · 2023 · PMC10633964 · PMID 37946255

Europe PMC DOI

hedged sentence

0.0600

closest p · 1.2× alpha

0.0600

boldest claim

The sentences

did not reach statistical significancep = 0.06so close (0.05 < p ≤ 0.1)

Of note, patients with ECOG PS of 0–1 at apheresis had longer median PFS compared to those with ECOG PS of ≥ 2, however, this did not reach statistical significance (3.5 months vs. 1.3 months, respectively, p = 0.06, Additional file 1 : Figure S2).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.